Publicacions
-
Sánchez-Espino LF, Ivars M, Prat-Torres CS, Lavarino C, Gene-Olaciregui N, Rovira-Zurriaga C, Celis-Passini V, Miguel Bejarano Serrano and Baselga E.
Single dominant lesion in capillary malformation-arteriovenous malformation (CM-AVM) RASA1 syndrome
PEDIATRIC DERMATOLOGY . 41(5): 861-865.
-
Camiña-Conforto G, Ivars M, Sarquella-Brugada G, Carlos Valera Dávila, Salvador-Hernandez H, Rovira-Zurriaga C and Baselga E.
Phacomatosis pigmentokeratotica: Exploring extracutaneous comorbidities and topical therapy
PEDIATRIC DERMATOLOGY . 41(5): 904-907.
-
Azizi, AA, Hargrave, D, Passos, J, Wolkenstein, P, Rosenbaum, T, Santoro, C, Rosenmayr, V, Pletschko, T, Ascierto, PA and Salvador-Hernandez H.
Consensus recommendations on management of selumetinib-associated adverse events in pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
Neuro-Oncology Practice . 11(5): 515-531. Nº de cites: 3
-
Sanchez-Guixe E, Muiños F, Pinheiro-Santin M, González-Huici V, Rodriguez-Hernandez CJ, Avgustinova A, Lavarino C, González- Pérez A, Mora J and López-Bigas N.
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues
CANCER DISCOVERY . 14(6): 953-964. Nº de cites: 5
-
De Bortoli M, Ivars M, Revencu N, Nassogne MC, Lavarino C, Paco-Mercader S, Lammens M, Renders A, Dumitriu D, Helaers R, Boon LM, Baselga E and Vikkula M.
Epilepsy with faint capillary malformation or reticulated telangiectasia associated with mosaic AKT3 pathogenic variants
AMERICAN JOURNAL OF MEDICAL GENETICS PART A . 194(6): . Nº de cites: 3
-
Revencu N, Eijkelenboom A, Bracquemart C, Alhopuro P, Armstrong-Moron J, Baselga E, Cesario C, Dentici ML, Eyries M, Frisk S, Karstensen HG, Gene-Olaciregui N, Kivirikko S, Lavarino C, Mero IL, Michiels R, Pisaneschi E, Schönewolf-Greulich B, Wieland I, Zenker M and Vikkula M.
Assessment of gene-disease associations and recommendations for genetic testing for somatic variants in vascular anomalies by VASCERN-VASCA
ORPHANET JOURNAL OF RARE DISEASES . 19(1): 213-213. Nº de cites: 5
-
Gorostegui M, Muñoz JP, Pérez-Jaume S, Simao-Rafael M, Cristina Larrosa Espinosa, Garraus-Oneca M, Salvador-Marcos N, Lavarino C, Krauel L, Mañe S, Castañeda-Heredia A and Mora J.
Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy
Cancers . 16(9): . Nº de cites: 1
-
Fresno Cañada C, Gispets Parcerisas J, Del Prado-Sanchez C, Puigventós E, Pérez-Jaume S, Salvador-Hernandez H, Llorca Cardeñosa A and Prat-Bartomeu J.
DRI Triton SS-OCT applied to detect choroidal nodules in paediatric patients affected by NF1
Heliyon . 10(8): . Nº de cites: 1
-
Pinto EM, Fridman C, Figueiredo BC, Salvador-Hernandez H, Teixeira MR, Pinto C, Pinheiro M, Kratz CP, Lavarino C, Legal EAMF, Le A, Kelly G, Koeppe E, Stoffel EM, Breen K, Hahner S, Heinze B, Techavichit P, Krause A, Ogata T, Fujisawa Y, Walsh MF, Rana HQ, Maxwell KN, Garber JE, Rodriguez-Galindo C, Ribeiro RC and Zambetti GP.
Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility
Human Genetics and Genomics Advances . 5(1): 100244-100244. Nº de cites: 5
-
Viskochil, D, Wysocki, M, Learoyd, M, Sun, P, So, KR, Evans, A, Lai, FC and Salvador-Hernandez H.
Effect of food on selumetinib pharmacokinetics and gastrointestinal tolerability in adolescents with neurofibromatosis type 1-related plexiform neurofibromas
neuro-oncology advances . 6(1): . Nº de cites: 3